carbamazepine has been researched along with 22q11.2 Deletion Syndrome in 1 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perret, LC | 1 |
| Lodovighi, MA | 1 |
| Perret, O | 1 |
| Ibrahim, EC | 1 |
| Philip, N | 1 |
| Azorin, JM | 1 |
| Belzeaux, R | 1 |
1 other study available for carbamazepine and 22q11.2 Deletion Syndrome
| Article | Year |
|---|---|
Treatment of Comorbid Bipolar Disorder Improves Disabilities and Neuropsychological Functioning in DiGeorge Syndrome: A Case Report.
Topics: Adult; Anti-Infective Agents; Bipolar Disorder; Carbamazepine; Cognitive Dysfunction; Comorbidity; D | 2017 |